Over the past several months, OBEST has engaged >200 senior representatives from major stakeholder groups across Ontario's life-sciences sector. The 6-month strategic planning process has resulted in defined priorities and a plan for robust growth and commercial viability of the province's bioscience industry. Click here to view the full article in PDF format